Go to the profile of Andrea Bellelli

Andrea Bellelli

Prof., Sapienza University of Rome
Go to the profile of Nour
Nour

doctoral , Biochemistry

Go to the profile of Precious Owuamalam
Precious Owuamalam

Ph.D Student, University of Birmingham

Go to the profile of Roberto Contestabile
Roberto Contestabile

Associate Professor of Biochemistry, Sapienza University of Rome

My research activity has mainly concerned pyridoxal phosphate-dependent enzymes and vitamin B6 metabolism in bacteria and humans. Concerning PLP-dependent enzymes, I have dealt with their catalytic mechanism, catalytic promiscuity and evolution of catalytic activities, the design and experimentation of specific inhibitors, the mechanism of addition of PLP to apoenzymes and the folding mechanism. At the moment, I am mainly focused on the regulation of PLP biosynthesis and salvage pathways in bacteria and humans. In particular, I am interested in enzyme regulation mechanisms and transcriptional regulation, in the mechanism of PLP transfer to apoenzymes and in neurological disorders related to PLP metabolism. I teach Biochemistry, Biochemical Methods and Enzymology in Biological Sciences, Industrial Chemistry and Biotechnology courses at Sapienza University.
Go to the profile of Matteo Ardini
Matteo Ardini

Research associate, University of L'Aquila

Go to the profile of giusi pitari
giusi pitari

professor, university

Go to the profile of francesco angelucci
francesco angelucci

associate professor of molecular biology, University of L'Aquila

Go to the profile of Matti Turtola
Matti Turtola

Postdoc, Aarhus University

Go to the profile of Isabel Varela Nieto
Isabel Varela Nieto

Research Professor, CSIC

Dr. Isabel Varela-Nieto graduated and earned her doctorate in Chemistry, Biochemistry Section, at the University Complutense of Madrid (Spain). She has been a visiting guest scientist at the Medical Schools of Uppsala (FEBS Fellow, Sweden) and San Diego (MEC Sabbatical, USA). She is Professor of Research at the CSIC and group leader at the CIBER of rare diseases (CIBERER, ISCIII) in Madrid. From the early 1990s she has been studying hearing neurobiology and IGF-1 actions. She was the first Chair of the SEBBM Science for Society working group with which she actively collaborates. She is currently the president elect of the SEBBM and a member of the FEBS Network working group and FEBS Science and Society Committee.